ONXX

ONXX Articles

The short interest in biotech stocks is generally falling, judging by the short interest changes from August 31 settlement date versus the August 15 settlement date. We have tracked the key short...
The short interest in biotech stocks is generally rising, judging by the short interest changes from August 15 settlement date versus the July 31 settlement date. We have tracked the key short...
The short interest data is out from the July 31 settlement date and, with a couple of notable exceptions, short sellers generally have retreated from their gambles on biotech firms. For the period...
The three major US stock indexes opened lower this morning as the Bank of England left interest rates alone (our coverage here) and the European Central Bank (ECB) did the same (our coverage...
The three major US stock indexes opened higher this morning as markets were getting primed for the afternoon’s statement from the FOMC. Tomorrow’s announcement on interest rates from the European...
The three major US stock indexes opened lower this morning as Spanish 10-year bond yields rose sharply above 7% (our coverage here) and German magazine Der Spiegel published a story that suggested...
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall S. research calls this Monday morning. Biogen Idec Inc. (NASDAQ: BIIB) started as Outperform at Leerink...
The three major US stock indexes opened lower this morning after Spanish bond yields rose above 7% again and the country’s Valencia region asked for central government assistance in paying its...
Shares of Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) were halted for about half an hour this morning pending an announcement from the company. Shares were up 5.2% when trading in the stock was stopped....
The three major US stock indexes opened higher this morning as markets treated the Moody’s downgrade of 15 major banks as old news that was already baked into share prices (our coverage here and...
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Friday. Celgene Corporation (NASDAQ: CELG) Maintained Buy with target of $73.00...
The three major US stock indexes opened mixed this morning as markets reacted to weak PMI reports from both Germany and China (more coverage here). A flash reading on US PMI was also at its lowest...
Each and every morning 24/7 Wall St. reviews the top analyst upgrades and downgrades from Wall Street analysts.  Some of these move stocks in a serious way while others sometimes miss the mark. ...
Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) was already on the radar screens in biotech before this morning.  But news showing that the company’s cancer drug carfilzomib has received favorable FDA...
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Thursday. Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) Maintained Hold at Argus....